._老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":349109913,"tweetId":"349109913","gmtCreate":1617571271832,"gmtModify":1634520539011,"author":{"id":3572682061977022,"idStr":"3572682061977022","authorId":3572682061977022,"authorIdStr":"3572682061977022","name":"Weichao","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>.</body></html>","htmlText":"<html><head></head><body>.</body></html>","text":".","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/349109913","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohunote.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3 只被击败的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动不振已经感染了许多投资者。去年，成长股在纳斯达克-100指数击败了稳重的巨人道琼斯工业指数.不过，2021 年到目前为止，情况就不同了。大笔资金似乎正在流入所谓的“规避风险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>因此，几个月前的许多雄心勃勃的人现在陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，这片乌云中有一线希望：相当多具有强劲增长前景的股票以折扣价出售。这里有三只被击败的股票，甚至可以让你的钱翻倍，甚至更多。</blockquote> DermTech<blockquote>德姆泰克</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>德姆泰克（纳斯达克股票代码：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至 2 月第三周，其股价今年迄今已飙升超过 145%。然而，自那以后，医疗保健股已下跌超过 35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题是前面提到的成长型股票的普遍抛售。然而，DermTech 在其第四季度更新中也提供了令人失望的指导。该公司预计第一季度检测收入在 160 万美元至 190 万美元之间，而第四季度检测收入为 160 万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech 在接触医生方面仍然面临一些 COVID-19 阻力。不过，该公司的长期增长前景仍然光明。DermTech 继续为其首款产品色素性病变检测 (PLA) 收取商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的美国市场总额约为100亿美元。由于该公司目前的市值低于15亿美元，DermTech只需要占领这个市场的一小部分，就可以为投资者带来巨大的回报。</blockquote> Gores Holdings VI<blockquote>戈雷斯控股 VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>不久前，特殊目的收购公司（SPAC）股票非常受欢迎。这已经改变了很多。戈雷斯控股 VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至 2 月中旬，SPAC 的股价今年迄今已飙升超过 120%，但现在已较这些高点下跌了 40% 以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI 和空间数据公司 Matterport 于 2 月 8 日宣布，他们计划合并，Matterport 的股权价值约为 29 亿美元。但是Matterport应该能够相对快速地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>十年前，Matterport开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术列为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过 250,000 名客户，其中包括 13% 的财富 1000 强企业。然而，目前全球40多亿座建筑中只有不到1%是数字化的。这代表着马特波特2400亿美元的机会。该公司预计 2022 年收入将几乎翻一番，随后几年的增长将加速。</blockquote> Skillz<blockquote>技能</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>技能（纽约证券交易所股票代码：SKLZ）是这三只重挫股票中最大的输家。到 2 月初，这家移动游戏平台提供商的股价飙升近 120%，但随后又回吐了所有涨幅和部分涨幅。该股今年迄今已下跌超过 5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与 DermTech 和 Gores Holdings VI 一样，Skillz 也受到了市场远离成长型股票的负面影响。然而，该公司决定在公开募股中出售 1700 万股股票也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法让用户比其他领先的在线平台更多地参与其中。它也推动了巨大的增长。该公司2020年的收入几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>移动游戏市场去年总计860亿美元，并继续快速增长。Skillz应该能够增加其市场份额，因为它在国际上扩张，并在其平台上添加新的游戏类型。该公司与 NFL 的多年协议也可能带来巨大的推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz 看起来像是一只可以轻松让您的资金翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3 只被击败的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3 只被击败的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动不振已经感染了许多投资者。去年，成长股在纳斯达克-100指数击败了稳重的巨人道琼斯工业指数.不过，2021 年到目前为止，情况就不同了。大笔资金似乎正在流入所谓的“规避风险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>因此，几个月前的许多雄心勃勃的人现在陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，这片乌云中有一线希望：相当多具有强劲增长前景的股票以折扣价出售。这里有三只被击败的股票，甚至可以让你的钱翻倍，甚至更多。</blockquote> DermTech<blockquote>德姆泰克</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>德姆泰克（纳斯达克股票代码：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至 2 月第三周，其股价今年迄今已飙升超过 145%。然而，自那以后，医疗保健股已下跌超过 35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题是前面提到的成长型股票的普遍抛售。然而，DermTech 在其第四季度更新中也提供了令人失望的指导。该公司预计第一季度检测收入在 160 万美元至 190 万美元之间，而第四季度检测收入为 160 万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech 在接触医生方面仍然面临一些 COVID-19 阻力。不过，该公司的长期增长前景仍然光明。DermTech 继续为其首款产品色素性病变检测 (PLA) 收取商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的美国市场总额约为100亿美元。由于该公司目前的市值低于15亿美元，DermTech只需要占领这个市场的一小部分，就可以为投资者带来巨大的回报。</blockquote> Gores Holdings VI<blockquote>戈雷斯控股 VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>不久前，特殊目的收购公司（SPAC）股票非常受欢迎。这已经改变了很多。戈雷斯控股 VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至 2 月中旬，SPAC 的股价今年迄今已飙升超过 120%，但现在已较这些高点下跌了 40% 以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI 和空间数据公司 Matterport 于 2 月 8 日宣布，他们计划合并，Matterport 的股权价值约为 29 亿美元。但是Matterport应该能够相对快速地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>十年前，Matterport开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术列为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过 250,000 名客户，其中包括 13% 的财富 1000 强企业。然而，目前全球40多亿座建筑中只有不到1%是数字化的。这代表着马特波特2400亿美元的机会。该公司预计 2022 年收入将几乎翻一番，随后几年的增长将加速。</blockquote> Skillz<blockquote>技能</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>技能（纽约证券交易所股票代码：SKLZ）是这三只重挫股票中最大的输家。到 2 月初，这家移动游戏平台提供商的股价飙升近 120%，但随后又回吐了所有涨幅和部分涨幅。该股今年迄今已下跌超过 5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与 DermTech 和 Gores Holdings VI 一样，Skillz 也受到了市场远离成长型股票的负面影响。然而，该公司决定在公开募股中出售 1700 万股股票也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法让用户比其他领先的在线平台更多地参与其中。它也推动了巨大的增长。该公司2020年的收入几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>移动游戏市场去年总计860亿美元，并继续快速增长。Skillz应该能够增加其市场份额，因为它在国际上扩张，并在其平台上添加新的游戏类型。该公司与 NFL 的多年协议也可能带来巨大的推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz 看起来像是一只可以轻松让您的资金翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":848,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/349109913"}